However, while HIF1α inhibits the progression of ccRCC [5], HIF2α serves as an oncogene primarily by supporting the ccRCC occurrence and development through the transcriptional activation of downstream genes [6,7]. Here, EPAS1 is linked to nonpapillary renal cell carcinoma.